Cafepharma Today

July 3 2025 - Summit said to be in talks with Astra to license potential rival for Merck’s Keytruda
Summit said to be in talks with Astra to license potential rival for Merck’s Keytruda
AstraZeneca board
Intuitive Surgical’s da Vinci 5 robot wins CE mark
Intuitive Surgical board
Novartis drug flunks phase 3 test in giant cell arteritis
Novartis board
Bluebird go-private deal signals the ‘PE-ization of pharma’
General Pharma Discussion board
*please scroll down for all the latest news*

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Summit said to be in talks with Astra to license potential rival for Merck’s Keytruda
Seeking Alpha
Thursday, July 3, 2025 - 11:50am
tags:
Summit Therapeutics, AstraZeneca, ivonescimab, Merck, Keytruda, lung cancer
Intuitive Surgical’s da Vinci 5 robot wins CE mark
Medtech Dive
Thursday, July 3, 2025 - 11:48am
tags:
Medtech, Intuitive Surgical, da Vinci 5, robotic surgery, Europe, CE Mark
Sage’s search for lifeline ran into defiant Biogen CEO
BioSpace
Thursday, July 3, 2025 - 11:46am
tags:
SAGE Therapeutics, Biogen, M&A, Zurzuvae
Sandoz, on a $1.1B investment spree in Slovenia, breaks ground at new $440M biosimilar plant
Fierce Pharma
Thursday, July 3, 2025 - 11:44am
tags:
Sandoz, generics, biosimilars, Slovenia, drug manufacturing
Torrent Pharma shells out $1.4B to take over controlling stake in India's JB Pharma from KKR
Fierce Pharma
Thursday, July 3, 2025 - 11:42am
tags:
Torrent Pharmaceuticals, India, JB Chemicals, KKR, M&A
Wearables take center stage in RFK Jr.'s personal health push
Axios
Thursday, July 3, 2025 - 11:39am
tags:
Robert F Kennedy Jr., Medtech, wearables
Dizal set to bring lung cancer drug Zegfrovy to US
Pharmaphorum
Thursday, July 3, 2025 - 11:35am
tags:
Dizal Pharmaceutical, Zegfrovy, FDA, sunvozertinib, China, non-small cell lung cancer
AI’s ‘massive transition’ in biopharma shapes leadership mindsets — tension and all
Pharma Voice
Thursday, July 3, 2025 - 11:29am
tags:
artificial intelligence, clinical trials, drug discovery, Parabilis Medicines, Sanofi, JNJ
Ascletis begins dosing in Phase IIa trial of ASC30 for obesity treatment
Clinical Trials Arena
Thursday, July 3, 2025 - 11:26am
tags:
Ascletis Pharma, weight loss, obesity, ASC30, clinical trials
Novartis drug flunks phase 3 test in giant cell arteritis
Pharmaphorum
Thursday, July 3, 2025 - 11:07am
tags:
Novartis, Cosentyx, clinical trials, giant cell arteritis
Bluebird go-private deal signals the ‘PE-ization of pharma’
BioSpace
Wednesday, July 2, 2025 - 10:11pm
tags:
private equity, Bluebird Bio
Fasikl’s Felix NeuroAI Wristband Gets FDA Clearance for Essential Tremor
Xtalks
Wednesday, July 2, 2025 - 10:05pm
tags:
Medtech, Fasikl, digital therapeutics, artificial intelligence, Felix NeuroAI, FDA, essential tremor
District court rules in favor of Tennessee’s 340B contract pharmacy law
American Hospital Association
Wednesday, July 2, 2025 - 7:42pm
tags:
legal, AbbVie, 340B, contract pharmacies
CDC Follows Advice of Ousted Vaccine Panel, Expands Access to RSV Shot
Medpage Today
Wednesday, July 2, 2025 - 7:38pm
tags:
CDC, ACIP, vaccines, RSV
Regeneron’s linvoseltamab receives FDA approval for multiple myeloma
Investing.com
Wednesday, July 2, 2025 - 11:29am
tags:
Regeneron, Lynozyfic, relapsed or refractory multiple myeloma, FDA
Gilead eyes HIV market domination with twice-yearly Yeztugo as GSK trails
BioSpace
Wednesday, July 2, 2025 - 11:25am
tags:
Gilead Sciences, PrEP, HIV, Yeztugo, GSK
Acadia CEO sets sights on ‘much more assertive’ deals to invigorate pipeline
BioPharma Dive
Wednesday, July 2, 2025 - 11:21am
tags:
Acadia Pharma, Pharma CEOs, Catherine Owen Adams, R&D
Biokin, having landed BMS deal, posts ph. 3 cancer win for bispecific ADC
Fierce Biotech
Wednesday, July 2, 2025 - 11:14am
tags:
Biokin, Bristol Myers Squibb, China, bispecific antibodies
Pfizer terminates study of CD47 in blood cancer due to low recruitment
Clinical Trials Arena
Wednesday, July 2, 2025 - 11:11am
tags:
Pfizer, clinical trials, CD47, maplirpacept
Organon drug for endometriosis falls short in mid-stage study
BioPharma Dive
Wednesday, July 2, 2025 - 11:09am
tags:
Organon, endometriosis, clinical trials, OG-621

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Assays Are Always Welcome
In the Pipeline
Down In the Reaction Details
In the Pipeline
The "Healthy Vaccinee" Effect
In the Pipeline
The Continuing Crisis, Part XVI: Get the Hell Out of Your Building
In the Pipeline
Tiny Crystals from Small Extracts
In the Pipeline
Hexanitrogen
In the Pipeline
Stir Bars Can't Be Ignored
In the Pipeline
AI Effects on Drug Patents
In the Pipeline
Mirror Morphine
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.